BINEX Co., Ltd. (KOSDAQ: A053030)
Health Care · Pharmaceuticals · KR
₩7,280.00
+9.15% today · -54.3% 1Y
BINEX Co., Ltd. (KOSDAQ: A053030) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $167.46M.
Over the last twelve months the share price has lost 54.3%, trading between 5.50K and 19.20K.
Tweenvest scores BINEX Co., Ltd. across four factors: quality 61/100, value 58/100, growth 44/100. Its strongest factor is quality.
A053030 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $167.46M
- Revenue (TTM)
- $107.74M
- P/E
- —
- EPS
- -403.67
- Dividend yield
- —
- Beta (5Y)
- 0.67
- 52-week high
- ₩19,200.00
- 52-week low
- ₩5,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 31.85M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.50 | -0.01% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.20 | +0.02% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.